These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30975400)

  • 41. Estimating EQ-5D utility values for major health behavioural risk factors in England.
    Maheswaran H; Petrou S; Rees K; Stranges S
    J Epidemiol Community Health; 2013 Feb; 67(2):172-80. PubMed ID: 22844084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utilities should not be multiplied: evidence from the preference-based scores in the United States.
    Fu AZ; Kattan MW
    Med Care; 2008 Sep; 46(9):984-90. PubMed ID: 18725854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in health-related quality of life of Chinese populations measured by the EQ-5D-3 L: a comparison of the 2008 and 2013 National Health Services Surveys.
    Yao Q; Liu C; Zhang Y; Xu L
    Health Qual Life Outcomes; 2019 Mar; 17(1):43. PubMed ID: 30866953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
    Pickard AS; Gooderham M; Hartz S; Nicolay C
    J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.
    Ahmad H; Taylor BV; van der Mei I; Colman S; O'Leary BA; Breslin M; Palmer AJ
    Mult Scler; 2017 Jul; 23(8):1157-1166. PubMed ID: 27698247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis.
    Sakthong P; Kasemsup V
    Value Health; 2012; 15(1 Suppl):S79-84. PubMed ID: 22265072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
    Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
    Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preference-Based EQ-5D index scores for chronic conditions in the United States.
    Sullivan PW; Ghushchyan V
    Med Decis Making; 2006; 26(4):410-20. PubMed ID: 16855129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D.
    Versteegh MM; Leunis A; Luime JJ; Boggild M; Uyl-de Groot CA; Stolk EA
    Med Decis Making; 2012; 32(4):554-68. PubMed ID: 22114301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia.
    Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Corte TJ; Glaspole I; Moodley Y; Goh N; Macansh S; Walters EH; Palmer AJ
    Qual Life Res; 2021 Sep; 30(9):2615-2632. PubMed ID: 33999322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis.
    Remenschneider AK; Scangas G; Meier JC; Gray ST; Holbrook EH; Gliklich RE; Metson R
    Laryngoscope; 2015 May; 125(5):1056-61. PubMed ID: 25431320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping the clinical chronic obstructive pulmonary disease questionnaire onto generic preference-based EQ-5D values.
    Boland MR; van Boven JF; Kocks JW; van der Molen T; Goossens LM; Chavannes NH; Rutten-van Mölken MP
    Value Health; 2015 Mar; 18(2):299-307. PubMed ID: 25773566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
    Lindkvist M; Feldman I
    Health Qual Life Outcomes; 2016 Sep; 14(1):134. PubMed ID: 27644119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping from disease-specific measures to health-state utility values in individuals with migraine.
    Gillard PJ; Devine B; Varon SF; Liu L; Sullivan SD
    Value Health; 2012 May; 15(3):485-94. PubMed ID: 22583459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling a preference-based index for two condition-specific measures (asthma and overactive bladder) using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; Yang Y
    Value Health; 2014 Jun; 17(4):406-15. PubMed ID: 24969001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Conditions Questionnaire (LTCQ): initial validation survey among primary care patients and social care recipients in England.
    Potter CM; Batchelder L; A'Court C; Geneen L; Kelly L; Fox D; Baker M; Bostock J; Coulter A; Fitzpatrick R; Forder JE; Gibbons E; Jenkinson C; Jones K; Peters M
    BMJ Open; 2017 Nov; 7(11):e019235. PubMed ID: 29101153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
    Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
    Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of health-related quality by multimorbidity groups in primary health care.
    Millá-Perseguer M; Guadalajara-Olmeda N; Vivas-Consuelo D; Usó-Talamantes R
    Health Qual Life Outcomes; 2019 Jan; 17(1):8. PubMed ID: 30634992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.